Both doses of orforglipron lowered blood sugar more than both doses of semaglutide
Tirzepatide, a dual GLP-1 / glucose-dependent insulinotropic polypeptide (GIP) agonist, was superior to semaglutide in reducing HbA 1c and body weight in the SURPASS-2 trial, a phase 3, randomised, open-label trial comparing the efficacy and safety of tirzepatide vs semaglutide once weekly as add-on therapy to metformin in individuals with type 2 diabetes [10]
If you prefer podcasts, listen to episodes All About Vitamin B12 Part 1 and Part 2
Free shipping on orders over $200
Contact the experts at Simply Slim in Bethesda, MD, Falls Church, VA, or Tysons Corner, VA to schedule your consultation today and start your weight loss journey.
CagriSema may serve those who need greater weight reduction, particularly patients with type 2 diabetes where REDEFINE-2 data are strongest [7]